2/5
06:10 am
slno
Soleno Therapeutics (NASDAQ:SLNO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
2/2
11:34 am
slno
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround [Yahoo! Finance]
1/29
08:17 am
slno
Soleno Therapeutics to Participate in Upcoming Conferences [Yahoo! Finance]
Medium
Report
Soleno Therapeutics to Participate in Upcoming Conferences [Yahoo! Finance]
1/29
08:00 am
slno
Soleno Therapeutics to Participate in Upcoming Conferences
Low
Report
Soleno Therapeutics to Participate in Upcoming Conferences
1/24
05:10 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/24
03:17 am
slno
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside [Yahoo! Finance]
Low
Report
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside [Yahoo! Finance]
1/23
07:09 pm
slno
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now? [Yahoo! Finance]
1/20
09:27 am
slno
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Low
Report
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
1/20
08:02 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
1/20
07:17 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/16
08:00 pm
slno
SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation
Low
Report
SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation
1/16
12:36 pm
slno
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
Low
Report
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
1/14
12:41 pm
slno
Soleno Therapeutics: Why I'm Staying On The Sidelines [Seeking Alpha]
Medium
Report
Soleno Therapeutics: Why I'm Staying On The Sidelines [Seeking Alpha]
1/13
10:02 am
slno
Soleno Therapeutics (NASDAQ:SLNO) was given a new $107.00 price target on by analysts at Robert W. Baird.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) was given a new $107.00 price target on by analysts at Robert W. Baird.
1/12
06:00 pm
slno
SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.
Low
Report
SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.
1/12
04:11 pm
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
Low
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
1/12
03:58 pm
slno
Soleno Therapeutics (NASDAQ:SLNO) was given a new $60.00 price target on by analysts at Wolfe Research.
Low
Report
Soleno Therapeutics (NASDAQ:SLNO) was given a new $60.00 price target on by analysts at Wolfe Research.
1/12
01:35 pm
slno
Soleno Therapeutics reports prelim Q4 rev above estimate [Seeking Alpha]
Low
Report
Soleno Therapeutics reports prelim Q4 rev above estimate [Seeking Alpha]
1/12
07:20 am
slno
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results [Yahoo! Finance]
Medium
Report
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results [Yahoo! Finance]
1/12
07:00 am
slno
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
Medium
Report
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
1/9
06:00 pm
slno
SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
Medium
Report
SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
1/9
03:38 am
slno
Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts [Yahoo! Finance]
Medium
Report
Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts [Yahoo! Finance]
1/8
10:00 am
slno
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
1/7
07:12 am
slno
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/6
12:47 pm
slno
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO